$77.57
00.00%
Pre-Market: Jul 19, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Sempra
SRENYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Sempra (NYSE:SRE) Stock, Analyst Ratings, Price Targets, Forecasts
Sempra has a consensus price target of $122.24 based on the ratings of 18 analysts. The high is $180 issued by Credit Suisse on April 26, 2022. The low is $76 issued by Morgan Stanley on June 24, 2024. The 3 most-recent analyst ratings were released by BMO Capital, Morgan Stanley, and Ladenburg Thalmann on July 10, 2024, June 24, 2024, and May 29, 2024, respectively. With an average price target of $79.67 between BMO Capital, Morgan Stanley, and Ladenburg Thalmann, there's an implied 2.70% upside for Sempra from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BMO Capital
Morgan Stanley
Ladenburg Thalmann
Mizuho
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Sempra
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/10/2024 | Buy Now | 8.29% | BMO Capital | James Thalacker | $86 → $84 | Maintains | Outperform | Get Alert |
| 06/24/2024 | Buy Now | -2.02% | Morgan Stanley | David Arcaro | $79 → $76 | Maintains | Equal-Weight | Get Alert |
| 05/29/2024 | Buy Now | 1.84% | Ladenburg Thalmann | Paul Fremont | $81.5 → $79 | Maintains | Buy | Get Alert |
| 05/17/2024 | Buy Now | 10.87% | Mizuho | Anthony Crowdell | $79 → $86 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | 8.29% | Wells Fargo | Sarah Akers | $79 → $84 | Maintains | Overweight | Get Alert |
| 03/21/2024 | Buy Now | -3.31% | Morgan Stanley | David Arcaro | $74 → $75 | Maintains | Equal-Weight | Get Alert |
| 03/14/2024 | Buy Now | 1.84% | Barclays | Eric Beaumont | $77 → $79 | Maintains | Overweight | Get Alert |
| 03/06/2024 | Buy Now | 5.71% | RBC Capital | Shelby Tucker | → $82 | Reiterates | Outperform → Outperform | Get Alert |
| 01/25/2024 | Buy Now | 1.84% | Mizuho | Anthony Crowdell | $83 → $79 | Maintains | Buy | Get Alert |
| 01/22/2024 | Buy Now | -0.73% | Barclays | Eric Beaumont | $76 → $77 | Maintains | Overweight | Get Alert |
| 01/11/2024 | Buy Now | 8.29% | BMO Capital | James Thalacker | $76 → $84 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/03/2024 | Buy Now | 5.07% | Ladenburg Thalmann | Paul Fremont | → $81.5 | Initiates | → Buy | Get Alert |
| 12/12/2023 | Buy Now | 10.87% | JP Morgan | Christopher Turnure | $78 → $86 | Upgrade | Neutral → Overweight | Get Alert |
| 11/21/2023 | Buy Now | -5.89% | Morgan Stanley | David Arcaro | $75 → $73 | Maintains | Equal-Weight | Get Alert |
| 10/25/2023 | Buy Now | -3.31% | Morgan Stanley | David Arcaro | $78 → $75 | Maintains | Equal-Weight | Get Alert |
| 10/24/2023 | Buy Now | -2.02% | Barclays | Eric Beaumont | $78 → $76 | Maintains | Overweight | Get Alert |
| 10/17/2023 | Buy Now | 0.55% | JP Morgan | Christopher Turnure | $82 → $78 | Maintains | Neutral | Get Alert |
| 10/04/2023 | Buy Now | 14.74% | UBS | Daniel Ford | $95 → $89 | Maintains | Buy | Get Alert |
| 09/21/2023 | Buy Now | 0.55% | Morgan Stanley | David Arcaro | $76 → $78 | Maintains | Equal-Weight | Get Alert |
| 09/06/2023 | Buy Now | 5.71% | RBC Capital | Shelby Tucker | $91 → $82 | Maintains | Outperform | Get Alert |
| 08/23/2023 | Buy Now | -2.02% | Morgan Stanley | David Arcaro | $79 → $76 | Maintains | Equal-Weight | Get Alert |
| 08/23/2023 | Buy Now | 101.11% | Barclays | Eric Beaumont | → $156 | Initiates | → Overweight | Get Alert |
| 08/07/2023 | Buy Now | 106.27% | BMO Capital | James Thalacker | $84 → $80 | Maintains | Market Perform | Get Alert |
| 08/04/2023 | Buy Now | 114% | Wells Fargo | Sarah Akers | $87 → $83 | Maintains | Overweight | Get Alert |
| 07/21/2023 | Buy Now | 103.69% | Morgan Stanley | David Arcaro | $79 → $79 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | Buy Now | 121.74% | Guggenheim | Shahriar Pourreza | → $86 | Reiterates | Buy → Buy | Get Alert |
| 07/07/2023 | Buy Now | 121.74% | Guggenheim | Shahriar Pourreza | $87 → $86 | Maintains | Buy | Get Alert |
| 06/23/2023 | Buy Now | 103.69% | Morgan Stanley | David Arcaro | $81.5 → $79 | Maintains | Equal-Weight | Get Alert |
| 06/08/2023 | Buy Now | 129.47% | Goldman Sachs | Carly Davenport | → $89 | Initiates | → Buy | Get Alert |
| 05/22/2023 | Buy Now | 110.13% | Morgan Stanley | David Arcaro | $82 → $81.5 | Maintains | Equal-Weight | Get Alert |
| 04/20/2023 | Buy Now | 111.42% | Morgan Stanley | David Arcaro | $75 → $82 | Maintains | Equal-Weight | Get Alert |
| 03/28/2023 | Buy Now | 112.71% | B of A Securities | Julien Dumoulin-Smith | $86.5 → $82.5 | Maintains | Buy | Get Alert |
| 03/21/2023 | Buy Now | 93.37% | Morgan Stanley | David Arcaro | $79 → $75 | Maintains | Equal-Weight | Get Alert |
| 03/01/2023 | Buy Now | 124.31% | Wells Fargo | Sarah Akers | $90 → $87 | Maintains | Overweight | Get Alert |
| 03/01/2023 | Buy Now | 114% | BMO Capital | James Thalacker | $84.5 → $83 | Maintains | Market Perform | Get Alert |
| 02/22/2023 | Buy Now | 103.69% | Morgan Stanley | Stephen Byrd | $80 → $79 | Maintains | Equal-Weight | Get Alert |
| 01/23/2023 | Buy Now | 106.27% | Morgan Stanley | Stephen Byrd | $81 → $80 | Maintains | Equal-Weight | Get Alert |
| 12/15/2022 | Buy Now | 108.84% | Morgan Stanley | Stephen Byrd | $76.5 → $81 | Maintains | Equal-Weight | Get Alert |
| 12/14/2022 | Buy Now | 132.05% | Wells Fargo | Sarah Akers | $84 → $90 | Maintains | Overweight | Get Alert |
| 11/11/2022 | Buy Now | 97.24% | Morgan Stanley | Stephen Byrd | $72 → $76.5 | Maintains | Equal-Weight | Get Alert |
| 10/21/2022 | Buy Now | 85.64% | Morgan Stanley | Stephen Byrd | $82.5 → $72 | Maintains | Equal-Weight | Get Alert |
| 10/19/2022 | Buy Now | 116.58% | Wells Fargo | Sarah Akers | $94.5 → $84 | Maintains | Overweight | Get Alert |
| 10/03/2022 | Buy Now | 107.55% | Mizuho | Anthony Crowdell | $86.5 → $80.5 | Maintains | Buy | Get Alert |
| 09/22/2022 | Buy Now | 112.71% | Morgan Stanley | Stephen Byrd | $84.5 → $82.5 | Maintains | Equal-Weight | Get Alert |
| 09/15/2022 | Buy Now | 143.65% | Wells Fargo | Sarah Akers | $92 → $94.5 | Maintains | Overweight | Get Alert |
| 08/23/2022 | Buy Now | 117.87% | Morgan Stanley | Stephen Byrd | $80 → $84.5 | Maintains | Equal-Weight | Get Alert |
| 07/21/2022 | Buy Now | 106.27% | Morgan Stanley | Stephen Byrd | $76 → $80 | Maintains | Equal-Weight | Get Alert |
| 07/18/2022 | Buy Now | 126.89% | Barclays | Eric Beaumont | $93 → $88 | Maintains | Overweight | Get Alert |
| 07/14/2022 | Buy Now | — | B of A Securities | Julien Dumoulin-Smith | — | Upgrade | Neutral → Buy | Get Alert |
| 07/06/2022 | Buy Now | 115.29% | Goldman Sachs | Michael Lapides | $82 → $83.5 | Upgrade | Neutral → Buy | Get Alert |
| 05/23/2022 | Buy Now | 111.42% | Morgan Stanley | Stephen Byrd | $84 → $82 | Maintains | Equal-Weight | Get Alert |
| 04/28/2022 | Buy Now | 120.45% | Citigroup | Ryan Levine | $71 → $85.5 | Maintains | Neutral | Get Alert |
| 04/26/2022 | Buy Now | 132.05% | Credit Suisse | Nicholas Campanella | → $90 | Initiates | → Outperform | Get Alert |
| 04/20/2022 | Buy Now | 116.58% | Morgan Stanley | Stephen Byrd | $81 → $84 | Maintains | Equal-Weight | Get Alert |
| 04/13/2022 | Buy Now | 129.47% | RBC Capital | Shelby Tucker | $79 → $89 | Maintains | Outperform | Get Alert |
| 03/30/2022 | Buy Now | 124.31% | Mizuho | Anthony Crowdell | $74 → $87 | Maintains | Buy | Get Alert |
| 03/24/2022 | Buy Now | 108.84% | Morgan Stanley | Stephen Byrd | $76 → $81 | Maintains | Equal-Weight | Get Alert |
| 03/22/2022 | Buy Now | 95.95% | Morgan Stanley | Stephen Byrd | $75.5 → $76 | Maintains | Equal-Weight | Get Alert |
| 03/07/2022 | Buy Now | — | Keybanc | Sophie Karp | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 02/18/2022 | Buy Now | 94.66% | Morgan Stanley | Stephen Byrd | $77.5 → $75.5 | Maintains | Equal-Weight | Get Alert |
| 01/27/2022 | Buy Now | 99.82% | Morgan Stanley | Stephen Byrd | $77 → $77.5 | Maintains | Equal-Weight | Get Alert |
| 01/25/2022 | Buy Now | 98.53% | Morgan Stanley | Stephen Byrd | $77.5 → $77 | Maintains | Equal-Weight | Get Alert |
| 01/21/2022 | Buy Now | 99.82% | Morgan Stanley | Stephen Byrd | $77 → $77.5 | Maintains | Equal-Weight | Get Alert |
| 01/13/2022 | Buy Now | 86.93% | Keybanc | Sophie Karp | $71 → $72.5 | Maintains | Overweight | Get Alert |
| 12/22/2021 | Buy Now | 85.64% | Mizuho | Anthony Crowdell | $69.5 → $72 | Maintains | Buy | Get Alert |
| 12/21/2021 | Buy Now | 98.53% | Morgan Stanley | Stephen Byrd | $74.5 → $77 | Maintains | Equal-Weight | Get Alert |
| 11/08/2021 | Buy Now | 86.93% | Wells Fargo | Sarah Akers | — | Maintains | Overweight | Get Alert |
| 10/19/2021 | Buy Now | 92.08% | Morgan Stanley | Stephen Byrd | — | Maintains | Equal-Weight | Get Alert |
| 10/19/2021 | Buy Now | 79.19% | Mizuho | Anthony Crowdell | — | Maintains | Buy | Get Alert |
| 10/19/2021 | Buy Now | 83.06% | Keybanc | — | — | Maintains | Overweight | Get Alert |
| 10/13/2021 | Buy Now | — | Goldman Sachs | Michael Lapides | — | Downgrade | Buy → Neutral | Get Alert |
| 09/28/2021 | Buy Now | 84.35% | Wells Fargo | Sarah Akers | — | Maintains | Overweight | Get Alert |
| 09/17/2021 | Buy Now | 99.82% | Morgan Stanley | Stephen Byrd | — | Maintains | Equal-Weight | Get Alert |
| 08/19/2021 | Buy Now | 101.11% | Morgan Stanley | Stephen Byrd | — | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Sempra (SRE) stock?
The latest price target for Sempra (NYSE:SRE) was reported by BMO Capital on July 10, 2024. The analyst firm set a price target for $84.00 expecting SRE to rise to within 12 months (a possible 8.29% upside). 24 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sempra (SRE)?
The latest analyst rating for Sempra (NYSE:SRE) was provided by BMO Capital, and Sempra maintained their outperform rating.
When was the last upgrade for Sempra (SRE)?
The last upgrade for Sempra happened on January 11, 2024 when BMO Capital raised their price target to $84. BMO Capital previously had a market perform for Sempra.
When was the last downgrade for Sempra (SRE)?
The last downgrade for Sempra happened on March 7, 2022 when Keybanc changed their price target from N/A to N/A for Sempra.
When is the next analyst rating going to be posted or updated for Sempra (SRE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sempra, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sempra was filed on July 10, 2024 so you should expect the next rating to be made available sometime around July 10, 2025.
Is the Analyst Rating Sempra (SRE) correct?
While ratings are subjective and will change, the latest Sempra (SRE) rating was a maintained with a price target of $86.00 to $84.00. The current price Sempra (SRE) is trading at is $77.57, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.